Monday 21 September 2020
Home      All news      Contact us      English
eaglenews - 2 month ago

US announces clinical trial of antibody treatment for COVID-19

WASHINGTON, United States (AFP) The US has begun late stage clinical trials into a drug formulated to fight COVID-19, officials said Tuesday. The medicine is an antibody against the new coronavirus called LY-CoV555, which was identified in the blood sample of a recovered patient by Canada s Abcellera Biologics. It was then developed synthetically for mass production by US-based Lilly Research Laboratories in partnership with Abcellera. The Phase 3 trial will initially enroll some [ ]


Latest News
Hashtags:   

announces

 | 

clinical

 | 

trial

 | 

antibody

 | 

treatment

 | 

COVID

 | 

Sources